CRDF - CIK 0001213037
The table below shows Cardiff Oncology, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.54M | $10.13M | $10.78M | $24.09M | $13.04M | $25.50M |
| Short-term investments | $37.51M | $50.46M | $60.17M | $55.79M | $44.63M | $34.82M |
| Receivables | $191.00K | $254.00K | $526.00K | $405.00K | $618.00K | $451.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $47.34M |
| $61.80M |
| $73.70M |
| $82.71M |
| $59.33M |
| $62.25M |
| Property, plant & equipment | $491.00K | $666.00K | $743.00K | $805.00K | $993.00K | $1.09M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $49.17M | $63.78M | $75.74M | $84.81M | $62.90M | $66.05M |
| Accounts payable | $5.48M | $2.44M | $6.01M | $3.63M | $4.64M | $5.11M |
| Total current liabilities | $14.46M | $14.71M | $16.67M | $13.29M | $12.53M | $12.52M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $14.46M | $14.99M | $17.13M | $13.93M | $13.50M | $13.66M |
| Retained earnings | -$442.38M | -$422.81M | -$411.56M | -$397.61M | -$372.39M | -$360.54M |
| Total equity | $34.71M | $48.79M | $58.61M | $70.88M | $49.39M | $52.39M |